Articles by S. L. Atkin (8)

Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target setting

T. Sathyapalan, S. L. Atkin and S. Kilpatrick

Diabetic Medicine 25 ( 8 ): 909 - 915 , 2008

For debate.Glucose variability and diabetes complication risk: we need to know the answer

E. S. Kilpatrick, A. S. Rigby and S. L. Atkin

Diabetic Medicine 27 ( 8 ): 868 - 871 , 2010

The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes

J. Ng, S. L. Atkin, A. S. Rigby, C. Walton and E. S. Kilpatrick

Diabetic Medicine 28 ( 5 ): 519 - 524 , 2011

Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database

E. S. Kilpatrick, A. S. Rigby, S. L. Atkin and B. M. Frier

Diabetic Medicine 29 ( 9 ): 1195 - 1198 , 2012

High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in Type 2 diabetes: a pilot randomized controlled trial

D. D. Mellor, L. A. Madden, K. A. Smith, E. S. Kilpatrick and S. L. Atkin

Diabetic Medicine 30 ( 4 ): 478 - 483 , 2013

Implications of new European Union driving regulations on patients with Type 1 diabetes who participated in the Diabetes Control and Complications Trial

E. S. Kilpatrick, A. S. Rigby, R. E. Warren and S. L. Atkin

Diabetic Medicine 30 ( 5 ): 616 - 619 , 2013

Biological variation of cardiovascular risk factors in patients with diabetes

A. J. Dawson, T. Sathyapalan, S. L. Atkin and E. S. Kilpatrick

Diabetic Medicine 30 ( 10 ): 1172 - 1180 , 2013

Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment

J. Konya, J. M. Ng, H. Cox, M. Cooke, N. Lewis, S. Bhandari, S. L. Atkin and E. S. Kilpatrick

Diabetic Medicine 30 ( 10 ): 1250 - 1254 , 2013